Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06561659 · ClinicalTrials.gov registry record · NA

Testing a Brief Exercise Intervention in Hoarding Disorder

A NA study, sponsored by Hartford Hospital.

Not yet
Registry status
NA
Development phase
22
Enrollment target

NCT06561659: Clinical Trial NA study, sponsored by Hartford Hospital.

NCT06561659 is a NA study that has not yet begun recruiting, run by Hartford Hospital. The registered enrollment target is 22 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06561659, a NA study, has not yet begun recruiting, sponsored by Hartford Hospital.

NOT YET RECRUITING
Registry status
NA
Development phase
22 participants
Enrollment target

Study Summary

Hoarding disorder (HD) is characterized by difficulty discarding personal possessions due to significant emotional distress when parting with personal items. This leads to the accumulation of excessive clutter which compromises the normal use of living spaces. In addition to emotional distress, individuals with HD experience significant impairment in physical health. One study found an 11-fold increase in stroke risk, a 10-fold increase in cancer risk, and a 7-fold increase in cardiovascular disease in individuals with HD relative to a general population comparison group. Patients with HD are also more likely to experience obesity and metabolic diseases such as diabetes. The short-term goal of the proposed study is to determine whether a brief exercise intervention improves discarding-related distress and brain-derived neurotropic factor (BDNF) in individuals with HD relative to a relaxation control condition. Preliminary evidence suggests that BDNF may be associated with greater body mass index and more severe HD symptoms in patients with HD. BDNF is a well-studied growth factor which is involved in neuronal transmission, plasticity, and survival of many neuron systems that have been implicated in psychiatric disorders, including serotonin, glutamate, and dopamine. BDNF has been proposed as a mechanism of exercise interventions for psychiatric disorders, as even one session of exercise has been shown to increase BDNF levels. This study represents an initial first step towards the long-term goal of improving current treatments for HD. This is important because although current cognitive-behavioral treatments (CBT) are effective, only 35% of patients who receive these treatments actually benefit from them. In the proposed pilot study, the investigators will test whether 30 minutes of moderate-intensity exercise reduces the distress associated with discarding and increases BDNF levels in individuals with HD relative to a relaxation control. The investigators will recr

Interventions

  • BEHAVIORAL Exercise Condition
  • BEHAVIORAL Relaxation Control Condition

Trial Details

FieldValue
Enrollment Target 22 participants
Start Date 2024-10
Est. Completion 2025-12
Phase NA
Hartford Hospital

75 total trials

What is known before NCT06561659 opens enrollment

NCT06561659 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 22 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 2 interventions - of which Exercise Condition is the first listed.

NCT06561659 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT06561659 about?

NCT06561659 is a clinical study titled "Testing a Brief Exercise Intervention in Hoarding Disorder". Hoarding disorder (HD) is characterized by difficulty discarding personal possessions due to significant emotional distress when parting with personal items. This leads to the accumulation of excessive clutter which compromises the normal use of living spaces. In addition to emotional distress, indi...

What is the current status of trial NCT06561659?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 22 participants. The study started on 2024-10. Estimated completion is 2025-12.

What interventions are being tested in trial NCT06561659?

The interventions under investigation include: Exercise Condition (BEHAVIORAL), Relaxation Control Condition (BEHAVIORAL).

Who is sponsoring clinical trial NCT06561659?

This trial is sponsored by Hartford Hospital, which has 75 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT06561659's enrollment target sits among peer trials

22 1756th of 2000 higher than 239 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02508038 · 22 participants · Phase 1

    Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors

  • NCT03099356 · 22 participants · Phase 2

    Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer

  • NCT03676647 · 22 participants

    Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules

  • NCT04569591 · 22 participants · NA

    DDAVP for Pituitary Adenoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT06561659, the US trial registry maintained by the National Library of Medicine. NCT06561659 (small enrollment · none site footprint · not yet recruiting) retrieved and formatted by PlainTrial, see methodology.